Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01799278 |
Title | A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer |
Recruitment | Completed |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Weill Medical College of Cornell University |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Chicago | Chicago | Illinois | 60637 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | United States | Details | |
Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | United States | Details | |
Weill Cornell Medical College | New York | New York | 10065 | United States | Details | |
Duke University Health System | Durham | North Carolina | 27710 | United States | Details | |
University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | United States | Details | |
University of Washington Medical Center | Seattle | Washington | 98195 | United States | Details |